Journal of Clinical Investigation · 2022 · 70 citations · 46 references
MedicineImmunologyNephrologyInflammationRenal PathologyRenal PathophysiologyImmune-mediated Renal DiseaseInflammatory Cell ResponsesRenal DiseaseRenal ImmunopathologyRenal InflammationSystemic Lupus ErythematosusB Cell-mediated Renal InjuryCd4 Positive T CellsCd8 Positive T CellsImmune-mediated NephritisImmunopathology Of Renal DiseaseInflammation In Renal InjuryPeriglomerular CellsSpatial Cell Segmentation
BACKGROUNDIn human lupus nephritis (LN), tubulointerstitial inflammation (TII) on biopsy predicts progression to end-stage renal disease (ESRD). However, only about half of patients with moderate-to-severe TII develop ESRD. We hypothesized that this heterogeneity in outcome reflects different underlying inflammatory states. Therefore, we interrogated renal biopsies from LN longitudinal and cross-sectional cohorts.METHODSData were acquired using conventional and highly multiplexed confocal microscopy. To accurately segment cells across whole biopsies, and to understand their spatial relationships, we developed computational pipelines by training and implementing several deep-learning models and other computer vision techniques.RESULTSHigh B cell densities were associated with protection from ESRD. In contrast, high densities of CD8+, γδ, and other CD4-CD8- T cells were associated with both acute renal failure and progression to ESRD. B cells were often organized into large periglomerular neighborhoods with Tfh cells, while CD4- T cells formed small neighborhoods in the tubulointerstitium, with frequency that predicted progression to ESRD.CONCLUSIONThese data reveal that specific in situ inflammatory states are associated with refractory and progressive renal disease.FUNDINGThis study was funded by the NIH Autoimmunity Centers of Excellence (AI082724), Department of Defense (LRI180083), Alliance for Lupus Research, and NIH awards (S10-OD025081, S10-RR021039, and P30-CA14599).
46
Erich Schubert, Jörg Sander, Martin Ester et al. · ACM Transactions on Database Systems · 2017 · 2.6K citations
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand, Richard Furie, Yoshiya Tanaka et al. · New England Journal of Medicine · 2019 · 1.3K citations · Full text
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Patrick Blanco, A. Karolina Palucka, Michelle A. Gill et al. · Science · 2001 · 1.3K citations